Makary and Center for Biologics Evaluation and Research Director Vinay Prasad unveiled a new framework in the New England Journal of Medicine on May 20 requiring a stronger evidence base for boosters ...

The results suggest toxicity may not be as pervasive as previously thought, which argues for more-personalized monitoring.